“…VCN has been mainly implicated in clinical and preclinical studies for the treatment of several Central Nervous System (CNS) disorders, such as cerebral ischemia, epilepsy, Alzheimer’s disease, and Parkinson’s disease 28 . In addition to this, VCN has been reported to show potential in the treatment of several inflammatory disorders, stress, glaucoma, and gastric disorders 29 ; in addition to these activities of VCN, a study published in 2021 by Choi et al about the anti-inflammatory effect of vinpocetine in a model of induced allergic asthma in mice made this agent interesting to investigate its activity in pulmonary fibrosis further 30 .…”